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Abstract
BACKGROUND: Inappropriate antibiotic prescribing is a well-documented global health crisis
(Centers for Disease Control, CDC, 2013). Antimicrobial stewardship (AS) is the purposeful
selection of the correct drug, dose, route and duration of antimicrobial treatment to decrease
microbial resistance, adverse drug effects and cost while improving patient outcomes (Dellit et
al., 2007; CDC, 2016). Antimicrobial Stewardship Programs (ASP) are multidisciplinary
programs designed to improve AS.
PURPOSE: To describe baseline prescribing patterns and evaluate the effect of an antimicrobial
stewardship program (ASP) for adult acute sinusitis on provider knowledge and antibiotic
prescribing practice. among primary care providers in an internal medicine clinic in an academic
medical center in Kentucky
METHODS: In this pre/post-test quasi-experimental design study a baseline chart audit was
conducted to determine baseline prescribing practices. An evidence based ASP was developed
and implemented to assess pre/post provider knowledge as determined by changes survey scores
after the education based ASP. Following the ASP, a focus group structured on the Health Belief
Model was conducted to elicit perceived barriers to deliver guideline recommended care.
RESULTS: The sample contained 22 patient chats for the baseline chart audit. The chart audits
revealed that care was concordant the majority (59.1%) of the time, the lowest scoring
component of the chart audit was timing (50%) and was significantly different between
concordant and unconcordant care. Eleven providers completed the pretest and participated in
the ASP and focus group 9 of the 11 providers completed the post-test 1 week after the ASP.
Overall knowledge increased from after the ASP
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(M = 52.27, SD =26.11) vs. (M = 55.56, SD = 24.3). Concordant care was delivered in 59.1% of
cases. Providers reported a desire for support in appropriate prescribing and in educating
patients on appropriate antibiotic use.
CONCLUSION: Care was concordant the majority (59.1%) of the time, and correct antibiotic
selection occurred 100%. Key areas for improvement include waiting for long enough symptom
duration … correct symptom duration. The ASP was feasible to implement and was well
received by attendees. Future ASP sessions should include a multidisciplinary team, multiple
sessions which include active participation, and communication skills. Future studies should
identify specific provider, clinical and patient components that influence the effectiveness of
outpatient stewardship programs.
Keywords: Antimicrobial Stewardship Program, Sinusitis, Adult, Antibiotics
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Adult Acute Sinusitis Antimicrobial Stewardship Program in a Primary Care Setting
Inappropriate antibiotic prescribing is a well-documented global health crisis (Centers for
Disease Control, CDC, 2013). The National Action Plan for Combating Antibiotic-Resistant
Bacteria calls for reducing inappropriate outpatient antibiotics by 50% by the year 2020 (The
White House, 2015). As many as 50% of outpatient antibiotics prescribed are unnecessary
and/or inappropriate (CDC, 2016) and acute respiratory conditions result in the most frequent
inappropriate antibiotic prescribing (Fleming et al, 2016). Thirty million adults report being
diagnosed with a sinus infection annually and although 84% of sinusitis cases are viral, 82.7%
of visits resulted in an antibiotic prescription (Blackwell, Lucas & Clarke, 2014; Sharp, Deman,
Puumala, Leopold, 2007). Due to gross misuse of antimicrobial agents, the Infectious Disease
Society of America (IDSA) along with the CDC advocate for the creation and implementation of
antimicrobial stewardship programs (ASPs) to promote prescription of the right drug, dose and
duration of antibiotics (CDC, 2013; Dellit et al., 2007; IDSA, 2011). The purpose of this study is
to improve antibiotic prescribing and stewardship related to adults with acute sinusitis in the
outpatient setting
Background
Antibiotic Use
An estimated 262.5 million antibiotics are prescribed each year (CDC, 2015).
Nationwide, five prescriptions are written for every six people (CDC, 2015). Kentucky has the
highest antibiotic prescribing rate in the country, with 1281 antibiotics prescribed per 1000
people (Hicks, 2014). Up to 50% of antibiotics prescribed are inappropriate, 33% are
unnecessary, and 64% of all antibiotics prescribed are written in the outpatient setting (Fleming
et al, 2016; Hicks, 2014). Respiratory tract infections receive the highest number of antibiotics
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in the outpatient setting (CDC, 2016). Inappropriate antibiotics are those which are an incorrect
drug, dose, route or indication. Unnecessary antibiotics are those prescribed without an
indication, such as too early in the natural course of a disease.
Resistance and Stewardship
Inappropriate antimicrobial use is described as prescription of non-optimal antibiotic
regimen, dose, duration and route (IDSA, 2011); it can cause iatrogenic harm such as clostridium
difficile (Dantes et al, 2015). Inappropriate antimicrobial use also contributes to the evolution of
bacterial resistance (Goossens, Ferech, Vander Stichele, & Elseviers, 2005). Antibiotic resistant
infections account for 20 billion dollars in health care costs and a loss of 35 billion dollars in
productivity each year (CDC, 2013). Superbug infections occur at a crude rate of 2 million
people infected annually in the United States, with 23,000 deaths directly due to resistant
infections (CDC, 2013). Due to these sequelae, the IDSA and the CDC advocate for the creation
and implementation of antimicrobial stewardship programs (ASPs) to promote prescription of
the right drug, dose, duration and route of antibiotics (CDC, 2013; Dellit et al., 2007; IDSA,
2011). ASPs are also aligned with The National Action Plan for Combating Antibiotic-Resistant
Bacteria, which has the goal for reducing unnecessary antibiotic use by 50% by the year 2020
(The White House, 2015).
Though ASP success within the inpatient setting has been validated by many studies,
fewer studies have been conducted in the outpatient and primary care settings (Arnold & Straus,
2005; Ranji, Steinman, Shojania & Gonzales, 2008; Song 2014). Research on inpatient
stewardship has taken precedence due to the 2013 CDC Antibiotic/Antimicrobial Resistance
Threat Report, which ranks Clostridium Difficile as an urgent resistance threat. Stewardship in
the outpatient setting is a currently evolving area of practice.
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To support outpatient stewardship, The CDC’s Get Smart: Know When Antibiotics Work
campaign (2016) identified four core elements of outpatient antimicrobial stewardship program
development: (a) Commitment to stewardship on a multidisciplinary level; (b) Action for policy
and practice to support stewardship; (c) Tracking and reporting of antibiotic use and drug
resistance; (d) education and expertise on current guidelines, practice behavior, and drug
resistance. These core elements are consistent with previous guideline and Cochrane Review
recommendations. The Core elements simplify the 2007 IDSA recommendations for ASP
creation and implementation and the 2005 Cochrane review of interventions for ambulatory
stewardship through organizing intervention by category, or element. The Get Smart campaign
also contains information for patients, providers, measurements, partnerships and references;
meaningful uses of this information ranges from vague to explicit (CDC, 2015).
Acute Sinusitis Antimicrobial Stewardship. Acute respiratory tract infections account
for the majority of inappropriate antibiotic prescriptions in the outpatient setting (Fleming et al,
2016; Blackwell, Lucas & Clarke, 2014). One in eight adults (30 million or 11.8% of adults)
report being diagnosed with a sinus infection every year (Blackwell, Lucas & Clark, 2014).
Consistent with other URIs, 84% of sinusitis cases are viral (Autio et al., 2015; Gwaltney,
Wiesinger, & Patrie, 2004), however 82.75% of outpatient sinusitis visits resulted in an antibiotic
prescription (Fairlie, Shapiro, Hersh & Hicks, 2012; Sharp, Deman, Puumala & Leopold, 2007).
Inappropriate antibiotic use for URI treatment, including sinusitis, is linked to antibiotic
resistance (Costelloe, Metcalfe, Lovering, Mandt, & Hay, 2010; Goossens, Ferech, Vander
Stichele, & Elseviers, 2005). Practicing stewardship for acute sinusitis is an important primary
care stewardship focus, since acute sinusitis accounts for the majority of outpatient antibiotic
prescriptions (15-21% of adult outpatient antibiotics) (Fairlie, Shapiro, Hersh & Hicks, 2012).
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The American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS)
published a 2015 clinical practice guideline update to improve appropriate antibiotic use for
acute sinusitis (Rosenfeld et al., 2015) The guideline update expanded the recommendation from
treating acute sinusitis with Amoxicillin to Amoxicillin with or without Clavulanate or watchful
waiting. Treatment should be initiated after 10 days of symptoms or the presence of double
sickening. Diagnostic symptoms of acute sinusitis are: purulent nasal drainage, with or without
nasal obstruction/congestion, and/or facial pain and pressure. The practice change supports
provider autonomy and accounts for regional resistance rates. Regional resistance rates to
Amoxicillin range to 35% for strep pneumonia, haemophilus influenza, and moraxella
catarrhalis, with susceptibility to Amoxicillin-Clavulanate of over 99% (IDSA, 2012). The CDC
endorses the Rosenfeld et al.’s 2015 AAO-HNS Clinical Practice Guideline Update as
recommended treatment for acute sinusitis (CDC, 2016).
In addition to finding 82.75% of acute sinusitis cases received an antibiotic, Fairlie et al.
(2012) analyzed population based surveys, National Ambulatory Medical Care Survey
(NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS) data, and
reported the nationwide proportion of antibiotics prescribed for adult acute sinusitis as follows:
amoxicillin with or without clavulanate (33%; 17% and 16% respectively), macrolide (29%),
quinolone (19%) and cephalosporin/other (19%). During the time period of Fairlie et al., 2012
study, the guideline recommended therapy was amoxicillin only, leading researchers to separate
amoxicillin (17%) from amoxicillin with clavulanate (16%) and state the most common
antibiotics prescribed for adult acute sinusitis were macrolides (29%) (Fairlie et al, 2012; Chow
et al, 2012). Combining amoxicillin with or without clavulanate to meet current guidelines
(Rosenfeld et al, 2015) indicates the most common antibiotics prescribed for adult acute sinusitis
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were amoxicillin with or without clavulanate (33%). For this project, amoxicillin with or
without clavulanate were combined to represent 33% of antibiotics prescribed for adult acute
sinusitis.
In addition to clinical practice guidelines, there are also quality measures through the
Centers for Medicare and Medicaid to provide financial incentive for guideline-adherent care.
The 2016 Physicians Quality Reporting System (PQRS, 2016) measure #331 recommends
treatment of adults with acute sinusitis with Amoxicillin with or without Clavulanate or watchful
waiting. PQRS #332 recommends ideal antibiotic treatment should occur after ten days and
before four weeks of symptoms or with the presence of double sickening (worsening of
symptoms after initial improvement). PQRS is a merit-based incentive payment system through
the Centers for Medicare and Medicaid (CMS) (CMS, 2015). Treatment information for
measures #331 and #332 is based on Rosenfeld et al.’s (2015) AAO-HNS evidence 2015 Clinical
Practice Update: Adult Sinusitis. Because of the potential influence on reimbursement and
recommendations consistent with the CDC’s practice guidelines, the PQRS measures #331 and
#332 served as the quality measures to help develop the education based ASP and evaluate
weather practice was consistent with guideline recommended care.
Purpose
The purpose of this study was to describe baseline prescribing patterns and evaluate the
effect of an antimicrobial stewardship program (ASP) for adult acute sinusitis on provider
knowledge and perceived practice. The objective was to evaluate the effect of the education
based ASP by comparing pre/post provider knowledge and practice. This purpose is consistent
with The National Action Plan for Combating Antibiotic-Resistant Bacterial (The White House,
2015), the IDSA (2011), and the CDC (2017).
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Specific aims:
•

Assess baseline antibiotic prescribing patterns for acute sinusitis in adult patients.

•

Develop and implement an evidence based ASP based on PQRS measures #331
and #332 for primary care providers

•

Evaluate effects of ASP implementation on provider knowledge related to
antibiotic prescribing standards for acute sinusitis in adults.
Methods

Design
This study was a pre-test/posttest quasi-experimental design with a descriptive
retrospective chart audit and focus group. The study contained three phases:
1. Phase 1: Baseline Assessment
•

Provider Knowledge: Survey on PQRS measures #331 and #332

•

Prescribing Patterns: Retrospective chart audit on diagnosis and treatment
of sinusitis per PQRS measures #331 and #332

2. Phase 2: Educational Intervention
•

ASP: created by the PI, based on the CDC recommendations and PQRS
measures #331 and #332

•

Focus group following ASP

3. Phase 3: Post Assessment
•

Provider Knowledge: Survey

•

Prescribing Patterns: Chart Audit

All aspects of this study were approved by the Institutional Review Board (IRB), Nursing
Research Council & Internal Medicine Research Council prior to implementation. This ASP was

8

evidence based, but only able to use two of the CDC’s four elements to outpatient antimicrobial
stewardship: tracking and reporting, and education and expertise (CDC, 2016).
Setting and Sample
This was a single center study, conducted at an internal medicine clinic in an academic
medical center in Kentucky. Two sample groups consisted of 1) providers and 2) patients
(indirectly through their medical records).
Providers. The provider population included voluntary non-resident primary care
providers (physicians, advance practice registered nurses, and physician’s assistants) at the
internal medicine clinic. Provider demographics were not collected to maintain anonymity with
a small sample size. Providers who participated in the focus group completed informed consent
forms. Those providers who completed the knowledge surveys were given survey cover letters
with a waiver of informed consent (Appendices A, B, C and D). All consent forms contained the
following information: purpose, risks, benefits, procedures, voluntary participation, anonymity,
counseling, and PI contact information.
Patients. Assessment of the patient population included a retrospective chart audit of 22
randomly sampled adult patients (>18 years) with ICD 9 or 10 codes (Table 3) for acute sinusitis
who were treated between March 15-June 15, 2016 at the internal medicine clinic. A random
selection of charts was performed by the UK Center for Clinical and Translational Science
(CCTS) Enterprise Data Trust (EDT). CCTS is a recognized as a third party honest broker and
data proprietor. Demographic information included: gender, age, race, and insurance type. A
waiver of informed consent was submitted for the retrospective chart audit since information
used was previously collected for non-research purposes.
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CCTS provided a list of 499 encounters with medical record numbers mined using a
query with the inclusion criteria of: adult patients (>18 years) treated between March 15-June 15,
2016 at the internal medicine clinic with ICD 10 codes for sinusitis (J01.00, J01.10,
J01.20, J01.30, J01.40, J01.80, J01.90). The majority of patient encounters were excluded for
the following reasons: (a) pediatric patient; (b) other outpatient clinic within the academic
medical center’s healthcare system; (c) duplicated medical record number; and (d) no diagnosis
of acute sinusitis.
Procedures
Phase 1.
Baseline retrospective chart audit. The baseline assessment chart audit was conducted on
a sample of 22 randomly selected adult (>18 years) patients seeking treatment at the internal
medicine clinic with acceptable acute sinusitis ICD codes (J01.00, J01.10, J01.20, J01.30,
J01.40, J01.80, J01.90) between March 15-June 15, 2016. Power analysis determined a
necessary sample size of 103 randomly selected adult patients to achieve a power of 80% with an
alpha of .05; however, data received from CCTS had insufficient patient numbers meeting the
inclusion criteria and only a total of 22 patients were eligible for review.
Patient variables assessed included: patient age, gender, race, and insurance type.
Clinical variables assessed were pertinent to the diagnosis and treatment of adult acute sinusitis,
and included: diagnosis of sinusitis, allergies, symptoms (including presence of double
sickening), timing of diagnosis, and treatment (including antibiotic prescription, indications for
an alternative to first-line antibiotic treatment, and dose of antibiotic). Key measures on the chart
audit tool examined if care was concordant or unconcordant to PQRS measures #331 and #332,
Concordant care was defined as correct documentation of: symptoms (purulent nasal drainage
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with or without facial pain and nasal obstruction), for the correct duration of time (10 days to 4
weeks OR double sickening) and treatment (selection of amoxicillin with or without clavulanate,
watchful waiting, or alternative treatment if indicated, and dose of antibiotic). Unconcordant care
was defined as antibiotic prescription without documentation of concordant symptoms, timing,
indication for alternative antibiotic to first-line treatment, or duration of dose.
Information was collected on a chart audit tool (Appendix E) and transcribed into excel
and SPSS. Information collected on the chart audit tool also included data related to PQRS
quality measures: PQRS #331 (when to prescribe an antibiotic for acute sinusitis) and #332
(what antibiotic to select). The baseline chart audit represents the tracking and reporting element
of stewardship.
Pre-test provider knowledge survey. The pre-test provider knowledge survey (Appendix
F) occurred during the first five minutes of the ASP and focus group session. Prior to the
education session, participants were asked to complete the pre-test survey. All surveys were
voluntary, de-identified, and provided to non-resident primary care providers. The pre-and postprovider knowledge surveys (Appendix F, G) were created by the PI and based on the quality
measures PQRS #331 and #332. The survey consisted of 6 items and contained a combination of
multiple choice and free text. Questions one and two asked if providers had prior awareness of
PQRS measures #331 and #332 respectively; questions three through six were pertinent to the
PQRS measure content for symptoms and treatment. Each of the four pertinent PQRS questions
was weighted to account for 25% of the score, with a total of 100%. Pre-and post-provider
knowledge surveys were identical. A total sample of 11 providers completed the pre-test and
were present for the ASP. The anonymous surveys were completed by hand and collected in
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person. No identifying information or demographics were collected on providers. Survey
responses were transcribed into excel and SPSS.
Phase 2.
Antimicrobial stewardship program and focus group. A total sample of 11 providers
participated in the ASP and focus group. The education based ASP was an evidence based power
point presentation developed by the PI using evidence review, including CDC fact sheet and
reviewed by her clinical mentor. Presented by the PI, the ASP covered: purpose, aims, and
background of antibiotic stewardship, along with the PQRS sinusitis measure group. The focus
group was structured on the Health Belief Model and facilitated discussion on perceived
susceptibility, severity, benefits and barriers to guideline recommended management of adult
acute sinusitis. The ASP with focus group lasted 30 minutes. The ASP represents the education
element of stewardship.
Phase 3.
Post-test provider knowledge surveys. Post-test provider knowledge surveys were
delivered one week after delivery of the ASP. Surveys were distributed to all non-resident
providers electronically via e-mail from the clinic manager. The e-mail contained links to the
REDCap survey with survey cover letter informing participants consent was indicated by
voluntary completion of the surveys. All surveys were voluntary, de-identified and provided to
non-resident primary care providers. Data was organized in excel spread sheets.
Post-test chart audit. The post-test chart audit was not feasible to complete due to time
restrictions. The goal for the post-test chart audit was a time-matched sample with the sample
patient inclusion criteria, to be performed after the ASP. The same chart audit tool and variables
were to be collected.
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Data analysis
Descriptive statistics, including frequency distributions, means (M), and standard
deviation (SD) were used to describe patients’ demographic characteristics. Continuous
variables were compared using the Independent Sample t-tests. For categorical variables, the chisquared test for independent samples was used, or Fishers exact test if values were less than 5 in
any cell. All was analyses were conducted using SPSS version 22; an [alpha] level of .05 was
used for statistical significance throughout.
Results
Participants
Providers. Clinic demographics include: 21 physicians, 6 advanced practice registered
nurses, and 1 physician’s assistant. Resident providers were not included to maximize
homogeneity over time. A convenience sample of 11 eligible providers were present and
consented to participation in the ASP. An additional 17 providers did not attend the luncheon
and could not be included. A total of 11 providers completed the pre-survey and 9 of these 11
completed the post-survey. No demographics were measured in order to protect anonymity in
this small sample. All of respondents of the post-test survey reported they completed the pre-test
and ASP, as indicated by a yes/no question and the of the post-test survey.
Patients. The total sample size of the group of patients identified for the chart audit
consisted of 22 patients. Patient demographics are displayed in Table 1. The sample included: 4
males and 18 females, ages ranging from 19 to 74 (M = 49.14, SD = 15.72); 18 white, 4 nonwhite, and 14 participants had private insurance, 2 had Medicare, and 6 had Medicaid. There
were no significant differences in gender, age, race or insurance and the delivery of guideline
concordant care or unconcordant care defined as documentation of: correct symptoms (purulent
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nasal drainage with or without facial pain and nasal obstruction), for the correct duration of time
(10 days to 4 weeks OR double sickening) and antibiotic selection (amoxicillin with or without
clavulanate, watchful waiting, or alternative treatment if indicated).
Phase 1
Baseline assessment. Medical records from the sample of 22 patients at the internal
medicine clinic with acute sinusitis ICD codes (J01.00, J01.10, J01.20, J01.30, J01.40, J01.80,
J01.90) were analyzed based on demographics, symptoms, duration of symptoms, antibiotic
selection, and dose (described in Figure 1). Evaluation of group differences in demographic
variables between patients receiving concord and unconcordant care was conducted and no
significant differences were found (Table 1).
Care Components. Care components assessed in the chart audits included documentation
of: Symptoms, timing, and treatment (antibiotic and dose). Concordant treatment consists of
appropriate symptoms, timing, antibiotic selection and dose duration. See figure 1.
Care concordant with the PQRS measures was delivered 59.09% of the time (n=13). This
includes 8 patients who received concordant antibiotics, and 5 who appropriately did not receive
antibiotics. Concordant symptoms were documented in 72.7% (n=16) of patients; concordant
timing of symptoms was documented in 50% (n=11) of patients, and concordant antibiotic
prescription was documented in 47.1% (n=8) of cases. Figure 1 shows the distribution of
patients among care components.
Table 2 further presents distribution of adherence to individual care components between
concordant and unconcordant care. Timing significantly differed between concordant and
unconcordant care (90.1% vs. 9.1%, P=.009*).
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Antibiotic use. Antibiotics were prescribed in 77.3% of cases (n=17), of those 17 cases,
41% (n =8) were Amoxicillin with or without clavulanate, 29.4% (n =5) were macrolides, 17.6%
(n = 3) were levofloxacin, and 11.8% (n=2) were doxycycline. Antibiotics were prescribed
concordantly with PQRS measures 47.1% (n=8) of the time, 52.9% (n=9) were not. Of the nonconcordant antibiotics prescribed, 88.9% (n=8) were unnecessary, and 11.1% (n=1) were for a
dose longer than recommended.
Frequency of antibiotic selection was similar between concordant and unconcordant care
(Table 2). There were no significant differences between groups receiving concordant vs.
unconcordant care across the following variables: receiving an antibiotic prescription (23.1% vs.
22.2%, P= .855), receiving Amoxicillin with or without clavulanate (38.5% vs. 22.2%, P =.735),
receiving a macrolide (15.4% vs. 33.3%, P = .683), receiving levofloxacin (15.4% vs. 11.1%, P
>.999), and receiving doxycycline (7.7% vs. 11.1%. P>.999). Though not statistically
significant, it is important to note amoxicillin with or without clavulanate was prescribed at a
higher rate in the concordant group (38.5% vs. 22.2%, P =.735), while macrolides were
prescribed at a higher rate in the unconcordant group (15.4% vs. 33.3%, P = .683).
First line antibiotics (amoxicillin with or without clavulanate) were prescribed 41% (n=8)
of the time, though only 71.4% (n=5) of these were included in concordant care. The remaining
28.6% (n=3) were prescribed to patients who did not have concordant symptoms documented for
the recommended duration; and thus were deemed unnecessary based on PQRS criteria? . Of all
non-first line recommended antibiotics, 100% (n=12) had a documented indication for an
alternative antibiotic treatment. The PQRS measures do not provide a recommended second line
treatment, but require documentation of an indication for an alternative. Given the parameter of
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first line treatment or documentation of an indication for an alternative with no second-line
treatment suggestions, 100% (n=17) of the antibiotics were selected appropriately.
Pre-test provider knowledge survey. A total of 11 providers participated in the pre-test
provider knowledge survey. The overall mean score for the provider knowledge survey was
52.27% (SD = 26.11) out of 100%. A score of roughly 50% indicates that on average providers
correctly answered two out of four questions on the survey. Within the pre-test provider
knowledge survey, 27.3% (n=3) providers were aware of PQRS measures #331 and #332. The
frequency of identification of correct answers is as follows: diagnostic symptoms, 63.6% (n=7);
duration of symptoms, 45.5% (n=5); first line antibiotic, 27.3% (n=3), and indication for
alternative antibiotic, 72.7% (n=8) (see Table 3).
Phase 2
Phase two consisted of the educational ASP and focus group. A total of 11 providers
participated in the ASP and focus group. The ASP was a power point presentation which
covered: purpose, aims, background antibiotic stewardship, and PQRS sinusitis measure group.
Following the ASP, the focus group was structured on the Health Belief Model and designed to
allow for discussion on perceived susceptibility, severity, benefits and barriers to guideline
recommended management of adult acute sinusitis. The ASP with focus group lasted 30
minutes.
During the focus group, providers reported barriers to practice included: lack of time,
pressure from patients, and lack of understanding from patients. Providers also reported that
support in appropriate antibiotic timing, and support in educating patients on symptom
management would help overcome the barriers to appropriate prescribing. Providers also gave
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positive feedback about the program as evidenced by parting statements of appreciation and
stating they were glad this specific need had been recognized.
Phase 3
Post-Test Provider knowledge surveys. A total of nine providers completed the post-test
provider knowledge survey. All post-test responders indicated they completed the pre-test, per a
yes/no question at the end of survey. The overall mean score for the post-test was 55.56% (SD =
24.30). An overall score of 55.56% still indicates roughly answering two out of four questions
correctly. Within the post-test provider knowledge survey, 66.7% (n=6) providers were aware of
PQRS measures #331 and #332. The frequency of identification of correct answers is as follows:
diagnostic symptoms, 33.3% (n=3); first line antibiotic, 33.3% (n=3), duration of symptoms,
55.5% (n=5); and indication for alternative, 100% (n=9). An independent-sample t-test was
conducted to compare the overall provider survey score for pre-and post-tests. The post-test
mean is higher than the pre-test, indicating gained knowledge from the ASP. However, there
was no significant difference in scores between the pre-test (M = 52.27, SD =26.11) and post-test
(M = 55.56, SD = 24.30; t (18) = -.288, p = .776, two-tailed). There were no significant
differences between frequency of correct answers on individual questions between pre-and postsurveys. Scores increased for all questions except the question on sinusitis symptoms (63.6% vs.
33.3%) (Table 4).
Practice vs. knowledge.
Frequencies of concordant care found in the chart audit and corresponding survey
questions were compared to examine provider practice alongside provider knowledge. No
statistical comparison could be made between documentation practices (as determined by the
chart audit) and knowledge (as determined by provider surveys) because the surveys were
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anonymous and no tracking occurred (Table 5). Per the chart audit, providers performed better
on symptom documentation than on the pre-and post-provider knowledge survey (77.3% vs.
63.6% vs. 33.3%) and alternative indication documentation (100% vs. 72.7% vs. 100%).
Concordant documentation and correct answers on timing and first line antibiotic selection as
similar between all three measures.
Post-Test chart audit. No data for the post-test chart audit and comparison was collected
due to time restriction. Data to be collected was identical to the baseline chart audit. Collecting
the same data would have allowed for comparison of prescribing behavior before and after ASP
to assess for changes.
Discussion
Findings from this descriptive study indicate that the majority of sinusitis cases treated by
providers in this internal medicine clinic were consistent per PQRS measures #331 and #332
[59.1% (n=13)]. However, among patients who received antibiotics, 47.1% of all antibiotics
prescribed were unnecessary and for 52.9% of the patients who received an antibiotic, the choice
of antibiotic prescribed was inappropriate. Among these inappropriate choices, 88.9% of were
deemed unnecessary because of an inadequate duration of symptoms at the time of prescription.
Secondly, the ASP was well received and in general mean knowledge scores increased from preto post-test. The major findings of this study are consistent with previous research that identified
timing as key component related to inappropriate antimicrobial prescribing (Pynonnen et al,
2015) and similar rates and frequencies compared to national averages for adult acute sinusitis
(Fairlie et al, 2012), and that communication and education support are important provider
perceived barriers than need to be addressed perceived provider barriers (Dempsey et al., 2014).
Further discussion of findings are presented in the following sections.
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Antibiotic Timing
In this study prescribing an antibiotic too early was the most likely reason for antibiotic
prescriptions to be unconcordant. Antibiotic timing was statistically significantly different
between concordant and unconcordant care (90.9% vs. 9.1%, P= .009). This is also consistent
with Pyonnen who found antibiotics were frequently prescribed too early in the disease course
(Pynnonen et al., 2015). Antibiotics prescribed outside of the time frame are considered
unnecessary because the patient does not meet the diagnostic criteria for acute sinusitis; these
findings are consistent with national trends of over prescribing antibiotics for acute sinusitis
because they are unnecessary (Fairlie et al, 2012; Rosenfeld et al., 2015).
Patients seeking an antibiotic too early is also consistent with barriers to guideline
recommended care as reported by providers in this study. This study and other qualitative
studies (Dempsey, 2014) report patient expectations for receiving an antibiotic prescription and
lack of knowledge realted to when antibiotics should be prescribed as barriers to delivering
guideline recommended care. Educating patients on the importance of correct timing for
treatment is a clear education opportunity for primary care providers and healthcare workers.
Successful education would help empower patients to manage symptoms, make environmental
modifications, decrease health care visits, and decrease unnecessary antibiotics.
Antibiotic Selection
In addition to timing, class of antibiotics prescribed was assessed. Antibiotic prescribing
trends are presented in figure 2 and are compared to national practice rates. No statistical
comparison could be made between the National Trend and internal medicine clinic because
sample sizes were not provided by researchers Fairlie et al., 2012 in their analysis of the
NAMCS and NHAMCS data between 2000 and 2009. Overall, in this small sample the internal
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medicine clinic appears to have lower rates of overall antibiotic prescribing (77.3% vs. 83%),
indicating less unnecessary antibiotics; and higher rates of selecting the first line antibiotic
Amoxicillin with or without Clavulanate (41% vs. 33%). The trend of less unnecessary
antibiotics and more appropriate first line antibiotics could be due to provider preference,
inclusion of resident providers within the chart audit, cost, and time. A recent study on sinusitis
prescribing patterns found resident and student providers have better antibiotic prescribing rates
than experienced providers (Pynnonen et al., 2015), it is possible that integration of resident with
attending providers in this clinic lead to fewer unnecessary and more appropriate antibiotics than
the national trend, which may be unique characteristics with academic medical centers.
As previously described in the results, antibiotics were prescribed concordantly with
PQRS measures 47.1% (n=8) of the time. Of the 52.9% (n=9) of antibiotics not prescribed
concordantly with the PQRS measures, 88.9% (n=8) were prescribed before 10 days of
symptoms without the presence of double sickening, indicating they were unnecessary. The
remaining 11.1% (n=1) of inappropriate antibiotic prescriptions was prescribed for 21 days,
greater than the recommended 5-10 days. First line antibiotics were selected 41% (n=7) of the
time. All cases with a non-first line treatment, including macrolides, had a documented
indication for an alternative treatment. This indicates 100% (n=17) of antibiotics were selected
appropriately per the PQRS quality measures.
Although the PQRS measures #331 and #332 do not provide a recommendation for
second line treatment (PQRS, 2016), the CDC recommends second line treatment as
Doxycycline or Levaquin, and to avoid macrolides (CDC, 2016). In this sample, macrolides
were prescribed in 29.4% (n = 5) of cases. If the PQRS adapts the CDC’s recommendation to
avoid macrolides, then the rate of inappropriate antibiotics would increase from 11.1% (n=1) to
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35.3% (n=6). Of the inappropriate antibiotics, 83.3% (n=5) would be due to the selection of a
macrolide as second-line treatment. Understanding discrepancies between guideline
recommended care and quality measure care will be helpful in anticipating future changes to
quality measures, as well as provide a deeper understanding of prescribing patterns. This reflects
an evolution of science and the translation of knowledge into practice since the PQRS measure
were published prior to the CDC recommendations. The CDC’s recommendations represent the
latest evidence. Though understanding current quality measures used by institutions is important
for standard practice, providers should also be aware of current evidence based practice to ensure
best practice
Lack of clear national benchmarks for antibiotic prescribing may be a factor in
prescribing practices because it makes progress difficult to measure. The White House National
Action Plan (2015) reported a goal of decreasing unnecessary antibiotics by 50% by the year
2020. The CDC reports over 30% of antibiotics are unnecessary (CDC,2016). While decreasing
unnecessary antibiotics by 50% by the year 2020 appears clear, to accurately measure a decrease
in unnecessary antibiotics, specific information on rates of unnecessary antibiotics are needed.
Understanding unnecessary antibiotic use requires more detailed reporting of antibiotic use and
clinical variables related to drug use.
In this study, macrolides were prescribed at similar rates between this sample size and the
national trend (Fairlie et al, 2012). In addition to being costly (Cramer et al, 2016) macrolides
have a lower efficacy rates for treating sinusitis (Anon et al., 2004) and higher rates of resistance
(IDSA, 2012). However, providers may be more likely to choose azithromycin because of a
shorter dose duration (5 vs 10 days), dosing (daily vs BID) and less frequent gastrointestinal side
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effects compared to Augmentin (RxList, n.d.). Education to providers and patients should
include emphasis on the cost, lack of efficacy, and resistance related to macrolide use.
ASP and focus group.
The ASP was created based on PQRS measures #331 and #332 and CDC’s (2016)
recommendations for diagnosis and treatment of acute sinusitis and presents the education
element of the CDC’s core elements of outpatient stewardship (CDC, 2016). A total of 11
providers participated in the ASP and focus group and it was well received. Though the sample
was too small to definitively assess a statistical difference between the pre-and post-surveys, , the
increase in mean scores suggests the ASP was effective in increasing knowledge
During the focus group, providers reported lack of time, pressure from patients, and lack
of understanding from patients as barriers to prescribing antibiotics per the PQRS
recommendations. Providers also reported interest in support for appropriate antibiotic timing
and patient education. Barriers expressed by providers in this study are similar to barriers found
in a recent qualitative survey of primary care providers by Dempsey and colleagues (2014) who
identified the following perceived barriers to appropriate antibiotic prescribing as: (a) patient
demand; (b) lack of accountability; (c) time and money saving; (d) treatment misconceptions; (e)
diagnostic uncertainty; and (f) fear of patient dissatisfaction.
Future education based ASPs could benefit from multidisciplinary collaboration (Arnold
et al, 2004), serial sessions, and inclusion of web-based modules or other active education
techniques (Ranji Steinman, Shjojania & Gonzales, 2008), communication training (Drekonja,
Filice, Greer & Olson 2015; van der Velden et al, 2012) and electronic clinical decision support
(McDonagh et al, 2016). These techniques are all endorsed by the CDC’s Get Smart, Know
When Antibiotic’s Work Campaign (CDC, 2016). In this focus group providers agreed that their
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biggest barrier was communication with patients regarding when antibiotics are appropriate. An
effective strategy to address this would be communication training, which involves patient
education on appropriate antibiotic use. This strategy would address reported perceived barriers
to guideline recommended care, and has been shown to decrease overall antibiotic prescribing
rates (Drekonja et al., 2015).
Though the key systematic reviews cited by the CDC have mixed conclusions on the
effect of various stewardship program components and approaches, each review which examined
communication skills training for patient interactions found significant reduction in overall
number of antibiotics prescribed (CDC, 2017) Further research on identifying influential
provider and patient factors is needed. Possible provider factors include years of experience,
area of specialty, and location of practice. Patient factors may be level of education, access to
follow up care, age, and possible comorbidities. Influential factors and specific ways to combat
these factors are needed to effectively overcome barriers to providing guideline recommended
care This need has been identified by similar studies (Pynnonen et al., 2015) and was confirmed
by the focus group in this study.
The focus group was held immediately after the ASP which was held during a scheduled
lunch hour. The scheduled time may have limited participation and attention of providers due to
the session occurring during a lunch period in the middle of a clinic day. Providers could have
been distracted by clinical issues and eating in a timely fashion. Separating the focus group and
ASP may have allowed for increased participation by allowing time to process ASP content
without usurping a lunch hour.
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Pre-test/posttest.
A total of 11 providers participated in the pre-test survey; and nine in the post-test survey.
All nine of the respondents from the post-test complete d the pre-test. Overall trend of mean
provider scores improved from pre-test (M = 52.27, SD =26.11) to post test (M = 55.56, SD =
24.30; t (18) = -.288, p = .776, two-tailed)., though not significantly. This is consistent with a
Cochrane review conducted by Arnold et al (2004) which reported only minor and observational
changes occurred after a single intervention; at this point in the ASP, providers had only received
the education component of the ASP, and no baseline chart audit with feedback had been
conducted. Scores increased for all questions pre-test to post-test except the question asking
about key symptoms (Table 5). Providers were able to identify fewer symptoms on the post-test.
Possible explanations include: the ASP and or question were not clear or valid measures of
knowledge, provider apathy, lack of clinical content for the survey question, and continued
influence effect from prior knowledge. Further inquiry via focus group is warranted to further
explore possible explanations.
Practice vs. knowledge.
Provider practice in general appeared to be similar or better than perceived provider
knowledge (Table 5). There are several possible reasons for this, though understanding them
definitively is not within the scope of this project. The clinical context of practice may act as a
cue to action for providers, allowing them to recognize clusters of symptoms more effectively
than to generate a list of symptoms on demand. The chart audit contained a random selection of
all providers, which could have captured a more accurate representation of the provider
knowledge base. Documentation is a representation of knowledge, and so may be a more valid
form of understanding provider knowledge than a survey.
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Limitations
A key limitation to this study was the small sample size for the baseline chart audit and
the provider knowledge surveys. The samples were too small to determine meaningful statistical
significance. The goal sample size was 120, however because of the sampling issues previously
discussed, the total sample for this study was only 22. It is possible the data was difficult to
mine with the given inclusion criteria, creating what appeared to be a large sample size.
Including all ICD-10 codes may have been too broad. Future studies should work with CCTS to
better define criteria for an improved sample. Narrowing down to the most frequently used
codes for acute sinusitis may have ensured patients selected would have the appropriate
diagnosis. Because many patients excluded were pediatric and ineligible, raising the age for
inclusion to 19 would ensure patients were 18 through the entire year of sampling, decreasing
possible pediatric patients.
Timing of the ASP and chart audit are an additional limitation. Initially, the ASP and
baseline chart audit were designed to occur during the late fall. Due to external circumstances,
the time frame was adjusted to the late spring with the hopes of completing a time-matched postASP chart audit. The post-ASP was not able to be completed, which unfortunately resulted in a
short time period for the baseline chart audit. In future studies, a broader period will be
requested in IRB applications to cover both fall and spring for inclusion of the influenza season
and to have a large pool of sinusitis cases from which to randomly select.
Research on outpatient stewardship has been ongoing during the development of this
project. Key resources published by the CDC’s Get Smart Campaign (CDC, 2016) were not all
available at the time of the project development, and should be included in future ASPs.
Continued research to standardize and validate education based ASPs and provider knowledge
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surveys is needed, along with more detailed tool kits to develop and implement stewardship
programs. Standard and validated ASPs and provider knowledge surveys would allow for larger
scale tracking of clinical, provider and population based data when combined with NAMCS and
NHAMCS
Practice Improvement Recommendations
General recommendations for outpatient stewardship improvement are for all outpatient
clinics to embrace the CDC’s four elements of outpatient stewardship of commitment, action,
tracking and reporting, and education and expertise (CDC, 2017). Providers and practices
should:
•

Commit to improving antimicrobial stewardship to decrease antimicrobial
resistance, adverse drug effects, and to improve patient outcomes.

•

Act to support antimicrobial stewardship practice policies on administrative,
research, and practice levels.

•

Track and report antibiotic use and resistance rates to understand personal,
clinic, and health care system prescribing and resistance patterns.

•

Educate and seek expertise on current practice guidelines, policy, and
stewardship practices.

Specific recommendations for improving antibiotic stewardship for sinusitis in the
internal medicine clinic evaluated in this project are for providers to commit to PQRS measure
#331 and #332 along with the CDC’s second line treatment recommendations for the diagnosis
and treatment of acute sinusitis as a standard of practice (PQRS, 2016; CDC, 2017).
Commitment should occur through engaged partnership through the CDC’s Get Smart
Campaign (CDC, 2016) active audits of provider prescribing, use of posters, and public health
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lectures for patients on acute sinusitis. Audits should be published to all providers in the clinic to
increase peer accountability (Meeker et al, 2016). Providers should act by clearly documenting
indications for selecting second line antimicrobial therapy. Administration should endorse a nomacrolide policy for the treatment of acute sinusitis unless all alternative treatments are
contraindicated (CDC, 2016). The clinic should track and report antibiotic frequencies and
allow for peer to peer comparison of rates (CDC, 2017). Finally, the clinic should collaborate
with pharmacy and infectious disease to develop multidisciplinary active education for providers
and patients on treatment guidelines and symptom management. Patient education should
include posters and printed material. Provider education should be free of charge and web based
to be taken at provider’s convenience (CDC, 2017)
Further Investigation
Project continuation. Further work should begin with establishing a more
representative baseline chart audit, and modifying the ASP to address limitation as previously
discussed. Creating a new baseline chart audit should obtain the desired sample of 103
randomly selected patients in this clinic. The chart audit should occur over the course of an
entire calendar year. A time-matched post ASP chart audit should be performed to assess for any
impact of the ASP as evidenced by changes in provider prescribing behavior. Once the ASP is
deemed effective in this site, it should be expanded to all primary care clinics in this healthcare
system.
The ASP should be developed with a multidisciplinary team and include the CDC’s Get
Smart About Antibiotic’s printed materials. Partnership with the CDC provides clinics and
clinicians with additional resources for stewardship. Education should be provided to patients
and providers. Provider education should be multiple sessions, active, and should remain free of

27

charge. Emphasis on the provider education should be on ways to communicate with patients
who expect an antibiotic, the importance of appropriate diagnostic criteria, first and second-line
treatment, and timing for treatment. Collaboration with administration and information
technology to investigate the possibility of an electronic medical record decision support tools
such as hard stop for non-first line antibiotic selection justification should be discussed. Patient
education should be provided during acute sinusitis visits and should be documented in the plan.
Outpatient stewardship. Future studies on outpatient stewardship should continue
examine the effectiveness of different techniques to modify provider prescribing behavior.
Education, peer accountability, electronic decision support tools and accountable justification
techniques have all been shown to decrease overall and unnecessary antibiotic prescribing,
though to varying degrees (CDC, 2016). Increased understanding of the effectiveness of
different interventions would help to improve stewardship (CDC, 2017). Knowledge on
intervention effectiveness should be included in a more specific outpatient stewardship tool kit,
which clinics and providers could implement for multiple disease processes. Additional research
is needed on identifying the most meaningful data to track for prescribing behavior and
resistance. Finally, research is needed on effective ways to modify patient expectations for
treatment (CDC, 2017; Dellit et al, 2007). Providers identified patient expectations and pressure
for antibiotics as a key barrier to the delivery of guideline recommended care. Furthermore,
research has shown that patient education sessions are also effective techniques at reducing
overall antibiotic prescribing rates (McDonagh, et al, 2016). An effective patient education arm
to the ASP would be helpful for this clinic.
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Conclusion
Antimicrobial stewardship is a multidisciplinary practice to improve antimicrobial
prescribing to improve patient outcomes, decrease adverse drug effects, and decrease costs
through adherence to clinical practice guidelines to promote appropriate treatment while
decreasing microbial resistance (CDC, 2016; Dellit et al, 2007). Antimicrobial stewardship
programs are multi-disciplinary programs designed to improve judicious use of antibiotics This
study was an education based antimicrobial stewardship program designed to assess current
provider prescribing behavior and knowledge and provide education on PQRS measures #331
and #332 to promote guideline adherent care. While the sample sizes were too small to
definitively state any meaningful statistical significance, the chart audit suggests the majority of
sinusitis cases are treated per PQRS guidelines [59.1% (n=13)]. However, the majority of
antibiotics were not prescribed concordantly [52.9% (n=9)]. The lowest scoring components of
treatment include timing and antibiotic selection [50% (n=11)]. When care was non-adherent,
the most likely factor was time, p=.009*
The provider knowledge survey results suggest knowledge increased after the ASP; pre
(M = 52.27, SD =26.11); post (M = 55.56, SD = 24.30; t (18) = -.288, p = .776, two-tailed). The
decrease score on the symptom questions suggests the ASP needs clarity on symptomology.
Finally, when comparing the provider knowledge surveys to the chart audit, it appears that
provider knowledge and practices are overall similar.
Further investigation is needed on the most effective strategies to improve outpatient
stewardship practices for providers and patients. Evidence based strategies for further
investigation have been provided in the discussion. Increased knowledge on effective outpatient
stewardship may help improve results of similarly designed studies, and overall improve patient
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outcomes through increased antibiotic stewardship for acute sinusitis and additional outpatient
diagnoses.
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Table 1
Demographics between concordant and unconcordant care.
Variable

Total

Concordant Unconcordant Significance

Age (m, sd)

49.1 (15.7)

54.9 (8.9)

45.2 (18.4)

Gender % (n)
Male 18.2 (4)
Female 81.8 (18)

P=.16
P >.999

50 (2)

50 (2)

61.1 (11)

38.9 (7)

Race (%)

P>.999
White 81.8 (18)

Non-White 18.2 (4)

61.1 (11)

38.9 (7)

50 (2)

50 (2)

Insurance (%)
Private 63.6 (14)

P=.367
50 (7)

50 (7)

Medicare 9.1 (2)

100 (2)

0 (0)

Medicaid 27.3 (6)

66.7 (4)

33.3 (2)

Table 1
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Table 2
Distribution of adherence to individual components of PQRS guidelines; Concordant Care vs.
Unconcordant Care %, ( n)
Total
Concordant
Unconcordant
Significance
N=22
n=13
n=9
P=
Symptoms

72.3 (16)

56.3 (9)

43.8 (7)

>.999

Timing

50 (11)

90.9 (10)

9.1 (1)

.009*

Double
Sickening
Antibiotic

4.6 (1)

100 (1)

0 (0)

>.999

77.3 (17)

58.8 (10)

41.2 (7)

>.999

First Antibiotic

31.8 (7)

71.4 (5)

25.6 (2)

.735

Alternative

50 (11)

54.6 (6)

45.5 (5)

>.999

Dose

59.1 (15)

60 (9)

40 (6)

>.999

Table 2
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Table 3
Antibiotic use between concordant and unconcordant care.
Concordant

Unconcordant

Significance

n=13

n=9

P=

No antibiotic

23.1 (3)

22.2 (2)

.855

Amoxicillin with or

38.5 (5)

22.2 (2)

.735

Z-pack

15.4 (2)

33.3 (3)

.683

Levofloxacin

15.4 (2)

11.1 (1)

>.999

Doxycycline

7.7 (1)

11.1(1)

>.999

without Clavulanate
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Table 4
Provider Knowledge Survey Scores; Frequency of correct scoring on individual components
between pre-and post-test
% (n)
Pre
Post
Trend Significance
N=11

N=9

P=

Total

52.27

55.56

↑

.776

Are you aware of PQRS measure #331?

27.3 (3)

66.7 (6)

↑

.190

Are you aware of PQRS measure #332?

27.3 (3)

66.7 (6)

↑

.190

What are the symptoms of acute sinusitis?

63.6 (7)

33.3 (3)

↓

.369

How many days after sinusitis symptom onset

45.5 (5)

55.5 (5)

↑

>.99

What is the first line antibiotic(s) of choice?

27.3 (3)

33.3 (3)

↑

>.99

What are at least three indications to not use

72.7 (8)

100 (9)

↑

.285

are antibiotics appropriate?

the first line antibiotic of choice?
Table 4
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Table 5
Frequencies of concordant care per Chart Audit vs. Correct answers on pre-and post-test
surveys
Chart Audit
Survey, Pre
Survey, Post
% (n)
% (n)
% (n)
N=22
N=11
N=9
Symptoms
77.27 (16)
63.6 (7)
33.3 (3)
Timing

54.6 (12)

45.4 (5)

55.5 (5)

First-Line Antibiotics

31.8 (7)

27.3 (3)

33.3 (3)

Alternative Indication 40.91 (9)

72.7 (8)

100 (9)

Dose

n/a

n/a

68.2 (15)

Table 5
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Figure 1. Distribution of care components
* : concordant
documentation
met
No asterix:
unconcordant
documentation
Blue: those who
received
concordant care

N=22
Symptoms

6

Timing
Treatment
and
antibiotic
selection

16*

4

2*

3

1*
Amoxicillin
Clavulanate
(n=1)

7

0

2*
Z-pack (PCN
allergy) (n=2)
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9*

2

5*
AmoxicillinClavulanate
(n=1)
Doxycycline
(PNC allergy)
(n=1)
Z-pack (PNC
allergy) (n=3)
Levaquin
(Immune
deficiency)
(n=1)

Levaquin (with
PNC allergy)
(n=1)
(Dose duration
too long)

1

8*
z-pack (with *
recent abx)
(n=1)
AmoxicillinClavulanate
(n=5)
Doxy (with
recent abx)
(n=1)
Levaquin (with
PCN allergy)
(n=1)

Figure 2. Proportions of antibiotics prescribed for acute sinusitis, National trends vs. UK
HealthCare General Internal Medicine & Geriatrics

Proportions of Antibiotics prescribed for Acute
Sinusitis, National Trend vs. UK HealthCare
Genderal Internal Medicine & Geriatrics
Percentage

100%
80%

83%

77.3%

60%
33%

40%

41%
29%

29.4%
19%

20%

17.6%

19%

11.8%

0%
Antibiotic

Amoxicillin with or without
clavulanate

Macrolide

Quinolone

Cephalosporin/Other

National Trend vs. Internal Medicine Group

National Trend

Internal Medicine Group

(Fairlie, Shapiro, Hersh & Hicks, 2012)
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Appendix A

Form F
Educational Intervention Cover Letter
To : UK General Internal Medicine and Geriatrics Providers:
The purpose of the study is to align antibiotic prescribing for adults with acute sinusitis with
PQRS measures #331 and #332 through: a) Assess current antibiotic prescribing patterns and
provider knowledge for acute sinusitis in adult patients, b), develop and implement an education
and evidence based ASP based on PQRS measures #331 and #332, and c) Evaluate provider
knowledge and practices before after ASP implementation to assess effect of ASP as evidenced
by changes in antibiotic prescribing and provider knowledge.
Although you will not get personal benefit from taking part in this research study, your
participation in the education session may offer meaningful insight to PQRS measurement
standards for the treatment of acute sinusitis. Minimal risks and discomforts are expected to be
associated with participation in this study. Benefits to participation include contributing to
knowledge of antibiotic prescribing patterns for adults with acute sinusitis and increased
knowledge of PQRS measurement standards associated with CMS reimbursement.

There are no known risks to participating in this study.
IF ANONYMOUS: Your participation in this study is anonymous which means no names
will appear or be used on research documents, or be used in presentations or publications. The
research team will not know that any information you provided came from you, nor even
whether you participated in the study.
Please be aware, while we make every effort to safeguard your data once received on
our servers via REDCap, given the nature of online surveys, as with anything involving the
Internet, we can never guarantee the confidentiality of the data while still en route to us.
If you have questions about the study, please feel free to ask; my contact information is
given below. If you have complaints, suggestions, or questions about your rights as a research
volunteer, contact the staff in the University of Kentucky Office of Research Integrity at 859-2579428 or toll-free at 1-866-400-9428.
Thank you in advance for your assistance with this important project.
Sincerely,
Katelyn Hellman
College of Nursing, University of Kentucky
PHONE: 616-881-9974
E-MAIL: kmde222@uky.edu
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Appendix B
Consent to Participate in a Research Study
Adult Acute Sinusitis Antimicrobial Stewardship Program in a Primary Care Setting
WHY ARE YOU BEING INVITED TO TAKE PART IN THIS RESEARCH?
You are being invited to take part in a research study about antibiotic prescribing for adults with
acute sinusitis. You are being invited to take part in this research study primary care providers are likely to
treat patients for acute sinusitis, which is the most common acute respiratory tract infection seen in the
primary care setting. If you volunteer to take part in this study, you will be one of about 30 people to do
so.
WHO IS DOING THE STUDY?
The person in charge of this study is Katelyn Hellman, RN, BSN, DNP(c) of University of
Kentucky, Department of College of Nursing. Ms. Hellman is a doctoral student and is being advised by
Dr. Elizabeth Tovar. There may be other people on the research team assisting at different times during
the study.
WHAT IS THE PURPOSE OF THIS STUDY?
The purpose of this study is to align antibiotic prescribing for adults with acute sinusitis with PQRS
measures #331 and #332 though: a) Assessment of current antibiotic prescribing patterns and provider
knowledge for acute sinusitis in adult patients, b) Develop and implement an education and evidence
based ASP based on PQRS measures #331 and #332, and c) Evaluate provider knowledge and practices
before after ASP implementation to assess effect of ASP as evidenced by changes in antibiotic prescribing
and provider knowledge.
By doing this study, we hope to learn current antibiotic prescribing patterns for adults with acute
sinusitis, provider knowledge of PQRS measures #331 and #332, and the impact of a brief educational
intervention.
ARE THERE REASONS WHY YOU SHOULD NOT TAKE PART IN THIS STUDY?
There are no known reasons why you should not participate in the educational intervention.
Participation in one aspect of this study does not mandate or preclude participation in the other aspects of
this study. Resident physicians will not be invited to participate in the follow-up survey to help ensure a
consistent sample of providers.
WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT LAST?
The research procedures will be conducted at UK General Internal Medicine and Geriatrics. You
will need to come to the staff meeting ON ESTABLISHED DATE/TIME/LOCATION one time during the
study. The visit will take about 30 minutes. The total amount of time you will be asked to volunteer for
this study is 40 minutes over the next year for the remainder of the education session and a follow up
survey.
WHAT WILL YOU BE ASKED TO DO?
As a participant, you will be asked to be present for an educational intervention on PQRS
measures #331 and #332. The PI will be collecting data on antibiotic prescribing behavior before and
after the intervention. No consequences will occur for choosing to not participate, to withdrawal, or to use
individual clinical judgement in treatment of adults with acute sinusitis.
Time-line:
1. October- November 2015: provider knowledge survey followed by education intervention
2. October or November and consecutive four months thereafter: retrospective chart audit for
antibiotic prescribing behavior from first business day after the education intervention and
consecutive four months, backdated 1 year.
3. April -May 2017: post-assessment chart audit for antibiotic prescribing behavior from first
business day after provider education intervention to four months thereafter; post-assessment
provider knowledge survey to be distributed the first Monday after completion of the four-month
chart audit time period.
WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS?
Potential risks and discomforts include: violating confidentiality for patient and provider
participants, embarrassment, frustration and negative evaluation. The PI has attempted to minimize risk
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by providing for patient and provider confidentiality and maintaining provider clinical decision making
autonomy. Education is supported by CMS through PQRS measures #331 and #332; provider autonomy
in clinical decision making remains unchanged. Participants may choose to withdraw from the study at
any time. No punitive or incentivized action will be taken against providers for sinusitis treatments. If
participants experience emotional distress from study participation, they can contact the PI for information
regarding free psychological services offered to employees of the University of Kentucky.
WILL YOU BENEFIT FROM TAKING PART IN THIS STUDY?
There is no guarantee that you will get any benefit from taking part in this study. You may have
increased understanding of PQRS measures #331 and #332 after the educational intervention. Your
willingness to take part may (a) help the University of Kentucky better understand antibiotic use rates for
acute sinusitis; and (b) help researchers understand effectiveness of educational antimicrobial
stewardship interventions.
DO YOU HAVE TO TAKE PART IN THE STUDY?
If you decide to take part in the study, it should be because you really want to volunteer. You will
not lose any benefits or rights you would normally have if you choose not to volunteer. You can stop at
any time during the study and still keep the benefits and rights you had before volunteering.
IF YOU DON’T WANT TO TAKE PART IN THE STUDY, ARE THERE OTHER CHOICES?
If you do not want to be in the study, there are no other choices except not to take part in the
study.
WHAT WILL IT COST YOU TO PARTICIPATE?
Costs for participating in this study include:
10 minutes for pre-intervention survey completion
30 minutes for education session
10 minutes for post-intervention survey completion.
WHO WILL SEE THE INFORMATION THAT YOU GIVE?
Data collected will be stored electronically on a secure server through the college of nursing.
Access to the database will be password protected. The database can be accessed on the PI’s password
protected encrypted laptop with VPN access. Informed consent will be stored in Dr. Tovar’s locked office
in a locked file cabinet.
The education portion of this study is de-identified. We will make every effort to keep confidential
all research records that identify you to the extent allowed by law.
Your information will be combined with information from other people taking part in the study.
When we write about the study to share it with other researchers, we will write about the combined
information we have gathered. You will not be personally identified in these written materials. We may
publish the results of this study; however, we will keep your name and other identifying information
private.
We will make every effort to prevent anyone who is not on the research team from knowing that
you gave us information, or what that information is.
For the survey, “Please be aware, while we make every effort to safeguard your data once
received on our servers via REDCap, given the nature of online surveys, as with anything involving the
Internet, we can never guarantee the confidentiality of the data while still en route to us.”
CAN YOUR TAKING PART IN THE STUDY END EARLY?
If you decide to take part in the study you still have the right to decide at any time that you no
longer want to continue. You will not be treated differently if you decide to stop taking part in the study.
ARE YOU PARTICIPATING OR CAN YOU PARTICIPATE IN ANOTHER RESEARCH STUDY
AT THE SAME TIME AS PARTICIPATING IN THIS ONE?
You may take part in this study if you are currently involved in another research study. It is
important to let the investigator/your doctor know if you are in another research study. You should also
discuss with the investigator before you agree to participate in another research study while you are
enrolled in this study.
WHAT HAPPENS IF YOU GET HURT OR SICK DURING THE STUDY?
If you believe you are hurt or if you get sick because of something that is due to the study, you
should call Dr. Tovar at (409) 599-5984 immediately.
•
•
•
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It is important for you to understand that the University of Kentucky does not have funds set aside
to pay for the cost of any care or treatment that might be necessary because you get hurt or sick while
taking part in this study. Also, the University of Kentucky will not pay for any wages you may lose if you
are harmed by this study.
The medical costs related to your care and treatment because of research related harm or
frustration and embarrassment will be your responsibility.
You do not give up your legal rights by signing this form.
WILL YOU RECEIVE ANY REWARDS FOR TAKING PART IN THIS STUDY?
You will not receive any rewards or payment for taking part in the study.
WHAT IF YOU HAVE QUESTIONS, SUGGESTIONS, CONCERNS, OR COMPLAINTS?
Before you decide whether to accept this invitation to take part in the study, please ask any
questions that might come to mind now. Later, if you have questions, suggestions, concerns, or
complaints about the study, you can contact the investigator, Katelyn Hellman at (616) 881-9974. If you
have any questions about your rights as a volunteer in this research, contact the staff in the Office of
Research Integrity between the business hours of 8am and 5pm EST, Mon-Fri at the University of
Kentucky at 859-257-9428 or toll free at 1-866-400-9428. We will give you a signed copy of this consent
form to take with you.
WHAT IF NEW INFORMATION IS LEARNED DURING THE STUDY THAT MIGHT AFFECT
YOUR DECISION TO PARTICIPATE?
If the researcher learns of new information in regards to this study, and it might change your
willingness to stay in this study, the information will be provided to you. You may be asked to sign a new
informed consent form if the information is provided to you after you have joined the study.
POTENTIAL FUTURE USE
Contacting Research Subjects for Future Studies
Do you give your permission to be contacted in the future by Katelyn Hellman or Dr. Tovar (regarding
your willingness to participate in future research studies about how to prevent, detect, or treat acute
sinusitis and the benefits of the education session?
Yes
No
_________Initials
WHAT ELSE DO YOU NEED TO KNOW?
There is a possibility that the data/tissue/specimens/blood collected from you may be shared with
other investigators in the future. If that is the case the data/tissue/specimen/blood will not contain
information that can identify you unless you give your consent/authorization or the UK Institutional Review
Board (IRB) approves the research. The IRB is a committee that reviews ethical issues, according to
federal, state and local regulations on research with human subjects, to make sure the study complies
with these before approval of a research study is issued.

_____________________________________________
Signature of person agreeing to take part in the study

____________
Date

_____________________________________________
Printed name of person agreeing to take part in the study
_____________________________________________
Name of [authorized] person obtaining informed consent
_________________________________________
Signature of Principal Investigator or Sub/Co-Investigator
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____________
Date

Appendix C

Form F
Survey Cover Letter
To : UK General Internal Medicine and Geriatrics Providers:
The purpose of the study is to align antibiotic prescribing for adults with acute sinusitis with
PQRS measures #331 and #332 through: a) Assess current antibiotic prescribing patterns and
provider knowledge for acute sinusitis in adult patients, b), develop and implement an education
and evidence based ASP based on PQRS measures #331 and #332, and c) Evaluate provider
knowledge and practices before after ASP implementation to assess effect of ASP as evidenced
by changes in antibiotic prescribing and provider knowledge.
Although you will not get personal benefit from taking part in this research study, your
responses may help us understand more about current antibiotic prescribing patterns for adults
treated for acute sinusitis. Minimal risks and discomforts are expected to be associated with
participation in this study.
We hope to receive completed questionnaires from about _30_ people, so your answers
are important to us. Of course, you have a choice about whether or not to complete the
survey/questionnaire, but if you do participate, you are free to skip any questions or
discontinue at any time.
The survey/questionnaire will take about _5-10_ minutes to complete.
There are no known risks to participating in this study.

Your response to the survey is anonymous which means no names will appear or be
used on research documents, or be used in presentations or publications. The research team
will not know that any information you provided came from you, nor even whether you
participated in the study.
Please be aware, while we make every effort to safeguard your data once received on
our servers via REDCap, given the nature of online surveys, as with anything involving the
Internet, we can never guarantee the confidentiality of the data while still en route to us.
If you have questions about the study, please feel free to ask; my contact information is
given below. If you have complaints, suggestions, or questions about your rights as a research
volunteer, contact the staff in the University of Kentucky Office of Research Integrity at 859-2579428 or toll-free at 1-866-400-9428.
Thank you in advance for your assistance with this important project. This survey will be
open between February 6th – February 10th.
Sincerely,
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Katelyn Hellman
College of Nursing, University of Kentucky
PHONE: 616-881-9974
E-MAIL: kmde222@uky.edu
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Appendix D

Form E
Include in IRB Application to
Waive Requirement for Informed Consent
If you are requesting IRB approval for waiver of the requirement for the informed consent
process, or alteration of some or all of the elements of informed consent (i.e. medical record review,
deception research, or collection of biological specimens), complete Section 1 and Section 2 of this form
and include it with your IRB application submission.
Note: The IRB does not approve waiver or alteration of the consent process for research that is
subject to FDA regulations, except for planned emergency/acute care research as provided under FDA
regulations. Contact ORI for regulations that apply to single emergency use waiver or acute care research
waiver (859-257-9428).

SECTION 1
Check the appropriate item:





1) I am requesting waiver of the requirement for the informed consent process.

2) I am requesting alteration of the informed consent process.

If you checked the box for this item, describe which elements of consent will be altered, and/or
omitted, and justify the alteration.



SECTION 2
The IRB may consider your request provided that all of the following conditions apply to your
research and are appropriately justified. Explain in the space provided for each condition how it applies
to your research.
a
)

The research involves no more than minimal risk to the subject.
The baseline chart review will be retrospective collect information on patients which has already
occurred. The post-assessment chart review will collect data after a voluntary education intervention which
intended to replace clinical judgement. The data will be collected retrospectively.
is not


)

b
The rights and welfare of subjects will not be adversely affected.
No identifying patient information will be maintained. Clinical judgement of providers will not be

compromised.


)

c
The research could not practicably be carried out with out the waiver or alteration.
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Data collected will be retrospective on 206 patients, informed consent cannot be obtained from
 patients without breaching confidentiality of treatment.
individual


d
Whenever possible, the subject will be provided with additional pertinent information after they
) have participated in the study.




Results of the study will be provided to UK General Internal Medicine and Geriatrics.
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Appendix E
Assessing Antibiotic Prescribing Behavior for Adults with Acute Sinusitis
Chart Audit Tool
Study number:_______________
Gender:_____________________
Age:________________________
Race:_______________________
Insurance:___________________
At adult acute bacterial sinusitis visits ICD9: 461.0, 461.1, 461.2, 461.3, 461.8, 461.9;
ICD10: J01.00, J01.10, J01.20, J01.30, J01.40, J01.80, J01.90, patient encounter codes
acceptable are: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99281, 99282,
99283, 99284, 99285, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326,
99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348,
99349, 99350
PQRS Measures
Information

Yes

No

Was the patient symptomatic for
greater than 10 days, less than 4
weeks
Was the patient exhibiting signs
and symptoms worsening within 10
days after initial improvement,
“double sickening”
Were the symptoms: purulent
nasal drainage, nasal obstruction,
facial pain-pressure-fullness or
both
Was the patient prescribed an
antibiotic?
Was the first-line antibiotic
amoxicillin with or without
clavulanate?
Was an allergy to penicillin
documented?
Was an indication to use
alternative first line treatment
documented?
Was the dose of antibiotic 5-10
days?
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Appendix F
Confidential

M1
Pre-Assessment Provider Knowledge
Survey
Please complete the survey below.

1)

Are you aware of PQRS measure #331?

Yes
No

2)

Are you aware of PQRS measure #332?

Yes
No

3)

How many days after sinusitis symptom onset are
antibiotics appropriate

3 days of diagnosis or 5 days of symptom onset
7 days of diagnosis or 10 days of symptom onset
7-10 days
3-5 days

4)

What is the first line antibiotics of choice?

Amoxicillin only
Amoxicillin-Clavulanate only
Macrolide
Amoxicillin with or without Clavulanate

5)

What are at least three indications to not use the
first line antibiotic of choice?

6)

What are key symptoms of acute sinusitis?
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Appendix G
Confidential

M2
Post-Assessment Provider Knowledge
Survey
Please complete the survey below.

1)

Are you aware of PQRS measure #331?

Yes
No

2)

Are you aware of PQRS measure #332?

Yes
No

3)

How many days after sinusitis symptom onset are
antibiotics appropriate

3 days of diagnosis or 5 days of symptom onset
7 days of diagnosis or 10 days of symptom onset
7-10 days
3-5 days

4)

What is the first line antibiotics of choice?

Amoxicillin only
Amoxicillin-Clavulanate only
Macrolide
Amoxicillin with or without Clavulanate

5)

What are at least three indications to not use the
first line antibiotic of choice?

6)

What are key symptoms of acute sinusitis?

7)

Did you complete the baseline provider knowledge
survey?

yes
no
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